| Literature DB >> 24996843 |
T Guillaume1, S Porcheron2, F Audat3, N Bancillon4, A Berceanu5, A Charbonnier6, R Dulery7, N Edy8, J El Cheikh9, E Hermet10, N Maurer11, F Paul12, J Konopacki-Potet13, P Turlure14, A Wallart7, F Boulanger15, N Dhédin16, F Suarez17, I Yakoub-Agha18.
Abstract
In the attempt to harmonize clinical practices between different French transplantation centers, the French Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC) set up the fourth annual series of workshops which brought together practitioners from all member centers and took place in September 2013 in Lille. Here, we report our recommendations regarding the use of donor lymphocyte injection (DLI) in the prophylactic, pre-emptive and curative settings. This work has been limited to allogeneic stem cell transplantations from an HLA-matched (10/10) or -one antigen-mismatched (9/10) donor.Entities:
Keywords: Cell therapies; Curatif; Curative; Donor lymphocyte injection; Immunotherapy post-allogeneic transplantation; Immunothérapie post-allogreffe; Injection de lymphocytes du donneur; Preemptive; Prophylaxie; Prophylaxis; Préemptif; Thérapie cellulaire
Mesh：
Year: 2014 PMID： 24996843 DOI： 10.1016/j.patbio.2014.05.011
Source DB: PubMed Journal: Pathol Biol (Paris) ISSN： 0369-8114